Role and mechanism of PTEN in Burkitt's lymphomaChuntuan Li(Fujian Medical University), Xiongpeng Zhu(Fujian Medical University)Oncology ReportsJanuary 9, 202010.3892/or.2020.7457Cited by 7SaveCiteExport RISWatch citationsRelated PapersResults of a registrational Phase 2 study of lisaftoclax monotherapy for treatment of patients (pts) with Relapsed/Refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who had failed Bruton's tyrosine kinase inhibitors (BTKis)|Blood|2025|0